1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6873D6E3C19423E6B85257AA0006E5BFB
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/government-affairs-public-policy-evaluate-structure-and-staffing-levels
18
19
2034.204.189.171
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Quality, Compliance and Regulatory » Government Affairs and Public Policy

Managing Healthcare Reform: Government Affairs and Public Policy Structure and Staffing for Engaging the Government Ecosystem

ID: 5227


Features:

13 Info Graphics

24 Data Graphics

250+ Metrics

5 Narratives


Pages/Slides: 45


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Managing Healthcare Reform: Government Affairs and Public Policy Structure and Staffing for Engaging the Government Ecosystem"


STUDY OVERVIEW

Healthcare reform is creating an even greater need for functions like Government Affairs and Public Policy to effectively monitor and engage the government healthcare sector. In the biopharmaceutical sector, Government Affairs and Public Policy are key players in terms of monitoring and engaging with governmental healthcare agencies. But the two functions also play a vital strategic role for organizations because they often communicate insights internally to commercial and strategic leadership. Two factors that affect the effectiveness of Government Affairs and Public Policy groups are the organizational structure and staffing levels that they have to operate within.

Best Practices, LLC conducted this research to help Government Affairs and Public Policy leaders evaluate how their structure and staffing levels compare with their industry peers. This study identifies how companies are structuring their Government Affairs and Policy groups as well as what the staffing levels - and outsourcing levels - typically are for the two groups. In addition, the study demonstrates where organizations place their Policy leadership (D.C. or headquarters) and the outsourcing levels for Government Affairs and Public Policy.

The study includes three segments: a Large Pharma Segment, a Mid-Cap Pharma Segment, and an Emerging Pharma segment.

KEY TOPICS

  • Government Affairs - How Companies Place Their Government Affairs Resources To Monitor & Manage Public-sector Healthcare Reform
  • Public Policy - How Companies Place Their Policy Resources To Monitor & Manage Public-sector Healthcare Reform
  • Government Affairs & Public Policy Staffing Benchmarks - What  Staffing Investments Are Companies Making To Manage the Government Ecosystem?
SAMPLE KEY METRICS
  • How is your U.S. Government Affairs organization structured
  • What is the Level of the Person Leading Your Government Affairs Group
  • What Leadership Group does Government Affairs Report to
  • What are all the Subgroups you Maintain within Government Affairs
  • Where is Your Public Policy Group Physically Located
  • Estimate the Percentage of Policy Staff in D.C., Headquarters and Brand Teams
  • What is the Level of the Person Who leads Your Policy Group
  • What is Policy's relation to Government Affairs
  • What Group Does Policy Report To
  • What is the Total Number of Employees within Your Government Affairs and Policy Groups
  • Indicate the Mix of U.S. Government Affairs and Policy Employees who are Internal and Outsourced

SAMPLE KEY FINDING
  • U.S. Government  Affairs & Public Policy Outsourcing: On average, companies in this study outsourced about 20% of their U.S. Government Affairs and Public Policy staff. The actual percentage was an average of 22.8% for GA staff and 20.1% for PP staff. There was not that much variation between the Large Pharma and Mid-Cap Pharma segments
METHODOLOGY

Best Practices, LLC engaged 23 experienced executives, mainly in Government Affairs, Public Policy and Managed Markets, from 23 different pharmaceutical companies. In addition, deep-dive interviews were conducted with six participating companies to gather additional insights.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Amylin; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Cubist; Daiichi-Sankyo; GE Healthcare; Genentech; GlaxoSmithKline; IDEA Pharma; Integrated Diagnostics; Merck; Millenium; Novo Nordisk; ProStraken; Purdue; Sagent; Sanofi; Shionogi; Shire; Smith & Nephew

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.